Find Clinical Trial

Home » Find Clinical Trials » Safety, Tolerability and Pharmacokinetics of S 95010 After Single Escalating Intravenous Doses in Young Healthy Male Subjects. A Randomised, Doubleblind, Placebo-controlled, Monocentre, First-In-Human Study

Safety, Tolerability and Pharmacokinetics of S 95010 After Single Escalating Intravenous Doses in Young Healthy Male Subjects. A Randomised, Doubleblind, Placebo-controlled, Monocentre, First-In-Human Study

← Back

Study Phase	Phase 1

Therapeutic Area	Cardiovascular Diseases

Indication	Heart failure

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	S095010

Active Substance Code	S095010

Protocol Code	CL1-95010-001

EudraCT Code	2017-004180-12

NCT Code	NCT03494712

Documents and links

Results summary	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.